Oncology & Cancer

First-in-class targeted microRNA therapy slows cancer tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported in Oncogene, tumors treated with the ...

Neuroscience

Study shows link between brain age and stroke outcomes

A new study lead by a team of researchers at the Keck School of Medicine of USC shows that younger "brain age," a neuroimaging-based assessment of global brain health, is associated with better post-stroke outcomes. The findings ...

Medical research

Immunotherapy reduces lung and liver fibrosis in mice

Chronic diseases often lead to fibrosis, a condition in which organ tissue suffers from excessive scarring. Researchers at the University of Zurich have now developed an immunotherapy that specifically targets the cause—activated ...

Neuroscience

Neuroscientists find new factors behind better vision

The size of our primary visual cortex and the amount of brain tissue we have dedicated to processing visual information at certain locations of visual space can predict how well we can see, a team of neuroscientists has discovered. ...

Oncology & Cancer

What makes some immune cells better at killing melanoma

T cells rely on surface proteins called T cell receptors (TCRs) to bind to and destroy viruses, cancer cells, and other invaders in the body. T cells that infiltrate tumors, however, can have varied, sometimes ineffective ...

page 1 from 2